AmerisourceBergen Corp (ABC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
November 2018
80
About the Report
About the Report
Summary
AmerisourceBergen Corp (AmerisourceBergen) is a pharmaceutical sourcing and distribution services company that provides pharmaceutical products, business solutions and value-driving services that improve access to care. The company distributes a broad offering of brand-name, specialty brand-name, over-the-counter (OTC) healthcare products, generic pharmaceuticals, equipment, home healthcare supplies, outsourced compounded sterile preparations and related services. It serves numerous healthcare providers in the US and selected global markets, comprising independent and chain retail pharmacies, acute care hospitals and health systems, medical clinics, mail order pharmacies, medical and dialysis clinics, physician practices, long-term care and alternate site pharmacies, veterinarians and other customers. AmerisourceBergen is headquartered in Chesterbrook, Pennsylvania, the US.
AmerisourceBergen Corp (ABC)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
AmerisourceBergen Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
AmerisourceBergen Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
AmerisourceBergen Corp, Medical Devices Deals, 2012 to YTD 2018 10
AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
AmerisourceBergen And Profarma Distribuidora de Produtos Farma Forms Joint Venture 12
Equity Offering 13
AmerisourceBergen Raises USD1.17 Billion in Private Placement of Shares up on Exercise of Warrants 13
Debt Offering 14
AmerisourceBergen Raises USD500 Million in Public Offering of 4.3% Senior Notes Due 2047 14
AmerisourceBergen Raises USD750 Million in Public Offering of 3.45% Senior Notes Due 2027 16
AmerisourceBergen Raises USD500 Million in Public Offering of 3.4% Notes 18
AmerisourceBergen Raises USD600 Million in Public Offering of 1.15% Notes 20
Acquisition 22
Walgreens Boots Alliance May Acquire Remaining 74% Stake in AmerisourceBergen 22
AmerisourceBergen Completes Acquisition of 19.9% Stake in Profarma Distribuidora de Produtos Farma for USD61.7 Million 23
H. D. Smith Completes Acquisition Of Remaining 49% Interest In Triplefin 24
Kohl & Frisch Completes Acquisition Of AmerisourceBergen Canada For Up To USD 100 Million 26
Walgreen And Alliance Boots Receive Regulatory Clearance To Acquire Up To 25% Stake In AmerisourceBergen 27
Triplefin Acquires Minority Stake In Specialty Pharmacy Nursing Network 29
H. D. Smith Wholesale Drug Completes Acquisition Of Valley Wholesale Drug 30
AmerisourceBergen Corp-Key Competitors 31
AmerisourceBergen Corp-Key Employees 32
AmerisourceBergen Corp-Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Recent Developments 36
Strategy And Business Planning 36
Aug 29, 2018: ICS opens new third-party logistics pharmaceutical distribution center 36
Jun 19, 2017: AmerisourceBergen Structures Operating Model and Executive Leadership Team to Offer a More Cohesive and Unified Customer Experience, Enhance Growth and Drive Long-Term Value 37
Financial Announcements 38
Aug 02, 2018: AmerisourceBergen posts fiscal 2018 Q3 results 38
May 02, 2018: AmerisourceBergen Reports Fiscal 2018 Second Quarter Results 39
Feb 06, 2018: AmerisourceBergen Reports Fiscal 2018 First Quarter Results 42
Nov 02, 2017: AmerisourceBergen Reports Fiscal 2017 Fourth Quarter and Year End Results 45
Aug 03, 2017: AmerisourceBergen Reports Third Quarter Fiscal Year 2017 Results 50
May 04, 2017: AmerisourceBergen Reports Second Quarter Fiscal Year 2017 Results 53
Jan 31, 2017: AmerisourceBergen Reports First Quarter Fiscal Year 2017 Results 56
Corporate Communications 59
Sep 10, 2018: AmerisourceBergen Announces Financial Leadership Change 59
May 15, 2018: Lash Group Launches Artificial Intelligence-Powered Electronic Benefit Verification Solution May 2018 60
Oct 04, 2017: AmerisourceBergen, Blue Cross Blue Shield Association, Pfizer and Prime Therapeutics Join Walgreens to Combat Prescription Drug Abuse by Expanding Safe Medication Disposal Program 61
Sep 19, 2017: AmerisourceBergen and the AmerisourceBergen Foundation Commit More Than USD 100,000 to Support Victims of Hurricanes Harvey and Irma 63
Legal and Regulatory 64
Oct 01, 2018: AmerisourceBergen to Pay USD 625 million to settle civil fraud allegations resulting from its repackaging and sale of adulterated drugs and unapproved new drugs, double billing and providing kickbacks 64
Aug 15, 2017: City of Birmingham and Legal Counsel Baron & Budd, Greene Ketchum, Levin Papantonio File Suit Against Pharmaceutical Distributors for Role in Creating Opioid Crisis 67
Jul 10, 2017: AmerisourceBergen Recognized as Best In Class for Specialty Distribution Quality 68
Jun 23, 2017: CPPA Accredits US Bioservices, a part of AmerisourceBergen, for Specialty Pharmacy 69
Government and Public Interest 70
Mar 09, 2018: The Moyer Foundation Receives Grant from the AmerisourceBergen Foundation to Launch New Community Program for Children Living with Addiction in their Families 70
Feb 15, 2018: AmerisourceBergen Comments on DEA's Creation of Transparency Resource to Help Distributors Combat Opioid Abuse 71
Nov 13, 2017: AmerisourceBergen Urges Policymakers to Support Regulator and Industry Data Transparency to More Effectively Combat Opioid Abuse 72
Product News 73
Feb 13, 2017: IntrinsiQ Specialty Solutions and ION Solutions Provide Independent Oncology, Urology Practices Improved Access to Clinical Trials with the Launch of AdvanceIQ Network 73
Other Significant Developments 74
May 30, 2018: US Bioservices Collaborates with MedImpact Direct to Support Hemophilia Patients 74
Dec 14, 2017: AmerisourceBergen Foundation Launches Municipal Support Program to Help Combat Opioid Abuse 75
Oct 04, 2017: Lash Group Launches Fusion, a New Technology Ecosystem to Power the Future of Patient Support Services 76
Aug 14, 2017: AmerisourceBergen Helps Innovators Navigate Commercialization for Cell and Gene Therapies 77
Jul 21, 2017: Good Neighbor Pharmacy Equips Independent Pharmacists to be Vital Source of Care in Today's Healthcare Environment 78
Mar 28, 2017: AmerisourceBergen enhances specialty medication management, storage solution Cubixx 79
Appendix 80
Methodology 80
About GlobalData 80
Contact Us 80
Disclaimer 80
List of Figure
List of Figures
AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
AmerisourceBergen Corp, Medical Devices Deals, 2012 to YTD 2018 10
List of Table
List of Tables
AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
AmerisourceBergen Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
AmerisourceBergen Corp, Deals By Therapy Area, 2012 to YTD 2018 9
AmerisourceBergen Corp, Medical Devices Deals, 2012 to YTD 2018 10
AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
AmerisourceBergen And Profarma Distribuidora de Produtos Farma Forms Joint Venture 12
AmerisourceBergen Raises USD1.17 Billion in Private Placement of Shares up on Exercise of Warrants 13
AmerisourceBergen Raises USD500 Million in Public Offering of 4.3% Senior Notes Due 2047 14
AmerisourceBergen Raises USD750 Million in Public Offering of 3.45% Senior Notes Due 2027 16
AmerisourceBergen Raises USD500 Million in Public Offering of 3.4% Notes 18
AmerisourceBergen Raises USD600 Million in Public Offering of 1.15% Notes 20
Walgreens Boots Alliance May Acquire Remaining 74% Stake in AmerisourceBergen 22
AmerisourceBergen Completes Acquisition of 19.9% Stake in Profarma Distribuidora de Produtos Farma for USD61.7 Million 23
H. D. Smith Completes Acquisition Of Remaining 49% Interest In Triplefin 24
Kohl & Frisch Completes Acquisition Of AmerisourceBergen Canada For Up To USD 100 Million 26
Walgreen And Alliance Boots Receive Regulatory Clearance To Acquire Up To 25% Stake In AmerisourceBergen 27
Triplefin Acquires Minority Stake In Specialty Pharmacy Nursing Network 29
H. D. Smith Wholesale Drug Completes Acquisition Of Valley Wholesale Drug 30
AmerisourceBergen Corp, Key Competitors 31
AmerisourceBergen Corp, Key Employees 32
AmerisourceBergen Corp, Subsidiaries 34
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.